HUTCHMED and AstraZeneca Initiate SACHI Phase III Trial of ORPATHYS® and TAGRISSO® Combination in Certain Lung Cancer Patients in China After Progression on EGFR Inhibitor Therapy

Go back to HUTCHMED and AstraZeneca Initiate SACHI Phase III Trial of ORPATHYS® and TAGRISSO® Combination in Certain Lung Cancer Patients in China After Progression on EGFR Inhibitor Therapy
ASTRAZENECA PLC (NASDAQ: AZN) Delayed: 59.48 -0.36 (0.6%)
Previous Close $59.84    52 Week High $35.04 
Open $59.60    52 Week Low $26.97 
Day High $59.85    P/E N/A 
Day Low $59.42    EPS $0.00 
Volume 3,563,956       

ASTRAZENECA PLC (NASDAQ: AZN) Delayed: 59.48 -0.36 (0.6%)
Previous Close $59.84    52 Week High $35.04 
Open $59.60    52 Week Low $26.97 
Day High $59.85    P/E N/A 
Day Low $59.42    EPS $0.00 
Volume 3,563,956       

ASTRAZENECA PLC (NASDAQ: AZN) Delayed: 59.48 -0.36 (0.6%)
Previous Close $59.84    52 Week High $35.04 
Open $59.60    52 Week Low $26.97 
Day High $59.85    P/E N/A 
Day Low $59.42    EPS $0.00 
Volume 3,563,956       

HANOVER CAPITAL MORTGAGE (NASDAQ: HCM) Delayed: 29.73 -0.81 (2.65%)
Previous Close $30.54    52 Week High $14.70 
Open $30.88    52 Week Low $9.80 
Day High $31.76    P/E N/A 
Day Low $29.52    EPS $-5.92 
Volume 269,950       

HANOVER CAPITAL MORTGAGE (NASDAQ: HCM) Delayed: 29.73 -0.81 (2.65%)
Previous Close $30.54    52 Week High $14.70 
Open $30.88    52 Week Low $9.80 
Day High $31.76    P/E N/A 
Day Low $29.52    EPS $-5.92 
Volume 269,950